Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 May;13(5):e240033.
doi: 10.57264/cer-2024-0033. Epub 2024 Mar 28.

R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 15

Alejandra Castanon  1 , Benjamin D Bray  1   2 , Sreeram V Ramagopalan  1   3
Affiliations

R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 15

Alejandra Castanon et al. J Comp Eff Res. 2024 May.

Abstract

In this latest update we discuss real-world evidence (RWE) guidance from the leading oncology professional societies, the American Society of Clinical Oncology and the European Society for Medical Oncology, and the PRINCIPLED practical guide on the design and analysis of causal RWE studies.

Keywords: ASCO; American Society of Clinical Oncology; ESMO; ESMO-GROW; European Society for Medical Oncology; PRINCIPLED; US Food and Drug Administration; artificial intelligence; data quality; health technology assessment; inferential studies; oncology; real-world data; real-world evidence; regulatory; target trial emulation.

PubMed Disclaimer

Conflict of interest statement

Competing interests disclosure

The authors have no financial and/or nonfinancial competing interests or relevant affiliations with any organization/entity to declare that are relevant to the subject matter or materials discussed in this manuscript. This includes employment, grants or research funding, consultancies, membership on scientific or other advisory boards, honoraria, stock ownership or options, paid expert testimony, patents received or pending, or royalties.

References

    1. IQVIA Global Oncology Trends 2023. Available at: https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publicati...
    1. Simpson A, Ramagopalan SV. R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment. J. Comp. Eff. Res. 10(10), 797–799 (2021). - PubMed
    1. Bray BD, Ramagopalan SV. R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 13. J. Comp. Eff. Res. 12(11), e230141 (2023). - PMC - PubMed
    1. Simpson A, Ramagopalan SV. R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 9. J. Comp. Eff. Res. 11(16), 1147–1149 (2022). - PubMed
    1. Simpson A, Ramagopalan SV. R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 10. J. Comp. Eff. Res. 12(1), e220194 (2023). - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources